Здоровье
Более половины мира сталкивается с высоким риском заражения корью
More than half of the world’s countries will be at high or very high risk of measles outbreaks by the end of the year unless
Препарат Johnson & Johnson от рака крови получил одобрение FDA США
The US Food and Drug Administration has approved Johnson & Johnson’s biweekly dose of Tecvayli blood cancer therapy. The approval allows the therapy to be
Исследование в США выявило 275 миллионов совершенно новых генетических вариантов
The study, which analysed the genetic code of a quarter of a million volunteers in the US, identified more than 275 million brand-new variants that
Регулятор ЕС по лекарственным средствам рассмотрит многодозовую ручку Lilly's Mounjaro
The European Union’s health regulator this week will review the use of Eli Lilly’s approved diabetes and obesity drug Munjaro in pre-filling a multi-dose injection
Препарат Pfizer для лечения воспалительных заболеваний кишечника получил одобрение ЕС
A drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission. The approval of Velsipity followed
FDA США одобрило комбинированную химиотерапию Тагриссо
The US Food and Drug Administration has approved a combination of AstraZeneca’s blockbuster drug Tagrisso with chemotherapy to treat a type of lung cancer. The
Препарат Денали-Санофи от БАС не достигает промежуточной цели
Drug developer Denali Therapeutics said its experimental drug for a fatal neurodegenerative disease failed to halt declining motor function in a mid-stage study. Following the
Асбестовый кризис обостряется в школах и супермаркетах Сиднея
Seven more public places in Sydney, including a school, a sports centre and a supermarket, are exposed to asbestos as contamination from the toxic material
FDA США одобрило комбинацию Тагриссо и химиотерапии компании AstraZeneca.
AstraZeneca’s combination of AstraZeneca’s blockbuster cancer drug Tagrisso with chemotherapy to treat a type of lung cancer has been approved by the US Food and
FDA США одобрило клеточную терапию рака кожи Iovance
Iovance Biotherapeutics the US health regulator has granted accelerated approval for a cell therapy for adult patients with advanced melanoma, the first such treatment approved